title: Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.
abstract: Progesterone is synthesized and actively metabolized in the central and peripheral nervous system, into neuroactive steroid metabolites, such as dihydroprogesterone, allopregnanolone and isopregnanolone. Progesterone and/or its metabolites exert a variety of effects acting as physiological regulators of neuronal and glial development and plasticity, controlling reproduction, neuroendocrine events, mood and affection. In addition, these neuroactive steroids maintain neural homeostasis and exert neuroprotective actions. In agreement, metabolic pathways of progesterone are affected by modifications in the level of gonadal hormones and by pathology or injury with a regional specificity and in a sex-dimorphic way. Therefore, observations here summarized may provide a background to design sex-specific therapies based on progesterone metabolites. On this point of view, considering that one of the major limits of a therapy based on neuroactive steroids could be modifications in their plasma levels and their consequent peripheral effects, pharmacological treatments aimed to increase their levels in the nervous system could provide an interesting therapeutic option.
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy. Electronic address: roberto.melcangi@unimi.it.
authors: Roberto Cosimo
authors: RC
authors: Melcangi
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Silvia
authors: S
authors: Giatti
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Donato
authors: D
authors: Calabrese
authors: Rotman Research Institute, Toronto, Ontario, Canada.
authors: Marzia
authors: M
authors: Pesaresi
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Gaia
authors: G
authors: Cermenati
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Nico
authors: N
authors: Mitro
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Barbara
authors: B
authors: Viviani
authors: Instituto Cajal, CSIC, E-28002 Madrid, Spain.
authors: Luis Miguel
authors: LM
authors: Garcia-Segura
authors: Dept. of Pharmacological and Biomolecular Sciences, Section of Biomedicine and Endocrinology, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.
authors: Donatella
authors: D
authors: Caruso
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D009420:Nervous System / Q000378:metabolism*; D019636:Neurodegenerative Diseases / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism*; D012727:Sex Characteristics
chemical_list: D011374:Progesterone
keywords: 3α,5α-tetrahydroprogesterone; 3α-HSOR; 3α-THP; 3α-hydroxysteroid oxidoreductase; 3β,5α-tetrahydroprogesterone; 3β-HSD; 3β-HSOR; 3β-THP; 3β-hydroxysteroid dehydrogenase; 3β-hydroxysteroid oxidoreductase; 5α-R; 5α-reductase; Allopregnanolone; CNS; DHP; EAE; Gonadectomy; Iba1; LC-MS/MS; LXR; MBP; Metabolism; Neuroactive steroids; Neurodegeneration; Neuroprotection; P0; P450 side-chain cleavage enzyme; P450scc; PMP22; PNS; PR; PREG; PROG; STZ; StAR; TSPO; WT; central nervous system; dihydroprogesterone; experimental autoimmune encephalomyelitis; glycoprotein zero; ionized calcium-binding adapter molecule 1; liquid chromatography tandem mass spectrometry; liver X receptor; myelin basic protein; peripheral myelin protein 22; peripheral nervous system; pregnenolone; progesterone; progesterone receptor; steroidogenic acute regulatory protein; streptozotocin; translocator protein of 18 kDa; wild type